How to evaluate physical fitness without a stress test?

Int J Cardiovasc Imaging. 2012 Jan;28(1):199-209. doi: 10.1007/s10554-010-9763-4. Epub 2010 Dec 9.

Abstract

To assess cardiorespiratory fitness (CF), usually a stress test is necessary. Our aims were to assess CF in a patient population with suspected or known coronary artery disease (CAD) based on a questionnaire (quest); to compare estimated CF with achieved workloads, and to evaluate its prediction of stress modality (physical/pharmacologic). Consecutive 612 patients undergoing myocardial perfusion SPECT (MPS) completed quest. They first chose one category which best described their daily physical activities. The second part contained patient characteristics (gender, age, BMI, and resting heart rate). An activity score was calculated and metabolic equivalents (METs) were estimated. Estimated and achieved results were compared. Patients with pharmacologic test (n = 208) provided a lower estimate of their performance than physically stressed patients (n = 404): 7.0 ± 2.1 and 8.2 ± 2.3 METs, respectively (P < 0.0001). The latter showed a good correlation between estimated and achieved METs (r = 0.63, P < 0.0001). Regarding prediction of the stress modality, area under the curve (ROC) was 0.65 (P < 0.0001). The quest can easily be applied in daily practice to assess CF in a patient population with CAD and for estimating whether an adequate physical stress test can be carried out.

MeSH terms

  • Aged
  • Coronary Artery Disease / diagnosis*
  • Coronary Artery Disease / diagnostic imaging
  • Exercise Test*
  • Female
  • Heart Rate
  • Humans
  • Male
  • Metabolic Equivalent
  • Middle Aged
  • Motor Activity
  • Myocardial Perfusion Imaging / methods
  • Physical Endurance
  • Physical Fitness*
  • Predictive Value of Tests
  • ROC Curve
  • Radiopharmaceuticals
  • Sensitivity and Specificity
  • Stress, Physiological
  • Surveys and Questionnaires*
  • Technetium Tc 99m Sestamibi
  • Tomography, Emission-Computed, Single-Photon / methods

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi